Jürgen Eck

MIG Verwaltungs AG is a private equity investment firm headquartered in Munich, Germany. It was founded in 2004 by entrepreneurs and financial institutions, to follow up on the success of the venture capital investment vehicles Global Chance Fund and Global Asset Fund, with which MIG's management had been involved.

MP Beteiligungs GmbH operates as an investment holding company. The firm’s focus areas encompass asset acquisition and management, investment management, project financing, and business consulting. Its investment and management operations involve businesses engaged in biotechnology research, real estate development and in the manufacture of automotive and aircraft seating. The company is headquartered in Kaiserslautern, Germany.

FIZ Frankfurter Innovationszentrum Biotechnologie GmbH is a market-oriented small and medium-sized enterprise in the field of life sciences. The company is based in Frankfurt, Germany. The German company provides a unique basis for innovation and growth. The company is ultimately controlled by the State of Hessen. The company was founded in 2002. Christian Garbe has been the CEO of the company since 2002.

Döhler Group SE engages in the production, sale, and distribution of natural fruit juice concentrates, basic substances, essences, essential oils, flavors and aromas, as well as other products and ingredients used in the beverages and spirits industry. The company was founded on January 19, 2016 and is headquartered in Darmstadt, Germany.

Herbstreith & Fox GmbH is a German company that processes fruits and vegetable juices. The company is based in Werder, Germany and has subsidiaries in the United States. The CEOs of the private company are Andreas Bernhardt and Gerhard Friedrich Fox.

Part of MP Beteiligungs GmbH, BSN GmbH is a German company that provides management services. The company is based in Kaiserslautern, Germany. The company was founded in 2004. The CEO is Ludger Müller.

Döhler GmbH operates as a producer, marketer, and provider of technology-driven natural ingredients. Its portfolio includes natural ingredients; ingredient systems; integrated solutions; and chain value. The firm serves the food and beverage industry. The company was founded by Lorenz Döhler in 1838 and is headquartered in Darmstadt, Germany.

Innovestnutrition GmbH is a German company that specializes in innovation in nutrition. The private company is based in Kaiserslautern, Germany. The company is backed by smart investments and are acting entrepreneurially. Martin B. Jager has been the CEO of the company since 2018.

Eit Food Ivzw is the world's largest and most dynamic food innovation ecosystem, supported by the European Institute of Innovation and Technology (EIT). The private company is based in Leuven, Belgium, and has subsidiaries in Belgium and Germany. The Belgian company invests in projects, organizations, and individuals that share their goals for a healthy and sustainable food system. The company unlocks innovation potential in businesses and universities, and create and scale agrifood startups to bring new technologies and products to market. Eit Food accelerates innovation to build a future-fit food system that produces healthy and sustainable food for all. Andy Zynga has been the CEO of the company since 2018.

Participations in South America II GmbH provides investment services. The private company is based in Kaiserslautern, Germany. The German company was founded in 2010. The CEO is Ludger Müller.

Part of Minor International Public Co., Ltd., NH Central Europe GmbH & Co. KG is a German company that operates hotels. The company is based in Berlin, Germany. The CEOs are Ramón Aragonés Marin, Stephan Peter Demmerle. The company was founded in 2003.

iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany.

apceth Biopharma GmbH operates as a contract development & manufacturing organization. The firm specializes in cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs). Its GMP services include quality management, quality control, assay development, process development, cell banking & formulation and project management. The company was founded in 2007 and is headquartered in Munich, Germany.

Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.

BIOCRATES Life Sciences AG operates as a research and technology. It provides metabolic phenotyping services. The firm products are absoluteIDQ p150 kit, p180 kit, sterio17 kit, steroid reagents, biocrates bile acids kit, and steroid kit. The company was founded by Gunther Bonn, Adelbert Roscher, and Hartmut Glossmann in 2002 and is headquartered in Innsbruck, Austria.

AMSilk GmbH engages in the production of fiber and biopolymers.It offers implant coating, medical devices for OTC wound care, functional cosmetics, cell biology device kits, biosteel spidersilk fibers and spidersilk research license. It serves the biosteel fibers, medical devices, and cosmetic ingredients industry. The firm's materials are to be applied in numerous fields to improve existing products or to develop materials for completely new applications, which could not be realized until now due to the lack of an appropriate material. The company was founded by Axel H. Leimer, Thomas Scheibel, and Lin Römer in 2008 and is headquartered in Planegg, Germany.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen operates as a research institute. The private company is based in Braunschweig, Germany. The CEOs of the German company are Bettina Fischer, Jörg Overmann.

Monteil Cosmetics International GmbH engages in the manufacture and sale of skincare products. The company was founded in 1936 and is headquartered in Dusseldorf, Germany.